Quest Diagnostics Inc (DGX)
Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell
$247.68
Buy
$263.99
$-1.01 (-0.40%)
Prices updated at 02 Nov 2026, 09:11 EST
| Prices minimum 15 mins delay
Prices in USD
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing w ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2025 | 33.21 |
| 2024 | 32.86 |
| 2023 | 33.00 |
| 2022 | 34.74 |
| 2021 | 39.02 |
| 2020 | 38.50 |
| 2019 | 34.80 |
| 2018 | 34.59 |
| 2017 | 36.25 |
| 2016 | 36.01 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2026 | 2.39 |
| 2025 | 1.82 |
| 2024 | 1.76 |
| 2023 | 1.69 |
| 2022 | 1.83 |
| 2021 | 2.05 |
| 2020 | 1.94 |
| 2019 | 1.91 |
| 2018 | 1.47 |
| 2017 | 1.80 |
| 2016 | 1.76 |
Price/Forward earnings (YTD)
20.96
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2025 | 6.10 |
| 2024 | 5.74 |
| 2023 | 6.33 |
| 2022 | 7.12 |
| 2021 | 14.39 |
| 2020 | 10.61 |
| 2019 | 7.17 |
| 2018 | 6.82 |
| 2017 | 7.46 |
| 2016 | 6.40 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2025 | 2.26 |
| 2024 | 2.38 |
| 2023 | 2.22 |
| 2022 | 2.18 |
| 2021 | 2.11 |
| 2020 | 2.08 |
| 2019 | 2.28 |
| 2018 | 2.11 |
| 2017 | 2.13 |
| 2016 | 2.18 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.